LAP-话题@MedSci

#LAP#

37篇内容 | 1651人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2227105, encodeId=b838222e10558, content=<a href='/topic/show?id=58dd1e34591' target=_blank style='color:#2F92EE;'>#TGF-β#</a> <a href='/topic/show?id=b42310e9537c' target=_blank style='color:#2F92EE;'>#低温电镜#</a> <a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Cell：挑战常规！新研究揭示TGF-β在被束缚在细胞膜上的情况下如何进行信号传导, objectType=article, longId=844368, objectId=d4ae8443689e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240922/1726994739745_2185383.png, objectUrl=/article/show_article.do?id=d4ae8443689e, replyNumber=0, likeNumber=16, createdTime=2024-09-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=安徽省, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1734681, encodeId=a1b31e3468117, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Clin Cancer Res: Olaparib(奥拉帕利)单药维持治疗亚洲人群铂敏感复发卵巢癌的疗效：III期临床研究L-MOCA, objectType=article, longId=295346, objectId=6f04295346b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f04295346b6, replyNumber=0, likeNumber=86, createdTime=2022-12-29, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f04295346b6, moduleTitle=Clin Cancer Res: Olaparib(奥拉帕利)单药维持治疗亚洲人群铂敏感复发卵巢癌的疗效：III期临床研究L-MOCA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f04295346b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734683, encodeId=9a801e34683a5, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=SLAP损伤机制与分型, objectType=article, longId=734500, objectId=9e58e34500a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e58e34500a5, replyNumber=0, likeNumber=77, createdTime=2023-06-11, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e58e34500a5, moduleTitle=SLAP损伤机制与分型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e58e34500a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734682, encodeId=ab4f1e34682e7, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Eur Urol Focus：机器人辅助与腹腔镜前列腺根治术：多中心随机对照LAP-01试验的12个月结果, objectType=article, longId=302123, objectId=1935302123dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1935302123dc, replyNumber=0, likeNumber=94, createdTime=2022-10-05, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1935302123dc, moduleTitle=Eur Urol Focus：机器人辅助与腹腔镜前列腺根治术：多中心随机对照LAP-01试验的12个月结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1935302123dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734680, encodeId=2f0b1e3468057, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Br J Cancer：Olaparib奥拉帕尼联合半胸放疗提高肺癌的治疗指数, objectType=article, longId=208933, objectId=66cb208933a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66cb208933a5, replyNumber=0, likeNumber=91, createdTime=2021-10-03, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66cb208933a5, moduleTitle=Br J Cancer：Olaparib奥拉帕尼联合半胸放疗提高肺癌的治疗指数, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66cb208933a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734679, encodeId=e53e1e346790d, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=ASCO GU 2021: ctDNA检测能有效判断Olaparib对去势抵抗性前列腺癌效果（PROfound研究）, objectType=article, longId=207230, objectId=677220e230b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=677220e230b0, replyNumber=0, likeNumber=90, createdTime=2021-05-29, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=677220e230b0, moduleTitle=ASCO GU 2021: ctDNA检测能有效判断Olaparib对去势抵抗性前列腺癌效果（PROfound研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=677220e230b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734678, encodeId=950c1e3467897, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=武田完成向Cheplapharm出售部分非核心资产, objectType=article, longId=205404, objectId=4db720540488, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4db720540488, replyNumber=0, likeNumber=69, createdTime=2021-03-21, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4db720540488, moduleTitle=武田完成向Cheplapharm出售部分非核心资产, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4db720540488)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734677, encodeId=f6061e34677fe, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=LYNPARZA（olaparib）联合贝伐单抗一线治疗HRD阳性晚期卵巢癌：已获FDA首肯, objectType=article, longId=193965, objectId=a65b19396562, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a65b19396562, replyNumber=0, likeNumber=77, createdTime=2020-07-17, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a65b19396562, moduleTitle=LYNPARZA（olaparib）联合贝伐单抗一线治疗HRD阳性晚期卵巢癌：已获FDA首肯, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a65b19396562)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734676, encodeId=501e1e346767e, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Gastroenterology：belapectin用于治疗非酒精性脂肪性肝炎、肝硬化和门脉高压患者, objectType=article, longId=192704, objectId=676e192e04a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=676e192e04a1, replyNumber=0, likeNumber=77, createdTime=2020-12-28, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=676e192e04a1, moduleTitle=Gastroenterology：belapectin用于治疗非酒精性脂肪性肝炎、肝硬化和门脉高压患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=676e192e04a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734675, encodeId=071d1e346751a, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Iclaprim不会在ABSSSI患者中引起高钾血症, objectType=article, longId=180593, objectId=b5f9180593b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5f9180593b8, replyNumber=0, likeNumber=92, createdTime=2020-01-06, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5f9180593b8, moduleTitle=Iclaprim不会在ABSSSI患者中引起高钾血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5f9180593b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734674, encodeId=27bf1e346747d, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Nat Commun丨傅阳心/黄秀梅合作破解抗癌药β-Lapchone抗肿瘤免疫机制, objectType=article, longId=176421, objectId=fa9b1e6421cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa9b1e6421cd, replyNumber=0, likeNumber=90, createdTime=2020-03-30, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa9b1e6421cd, moduleTitle=Nat Commun丨傅阳心/黄秀梅合作破解抗癌药β-Lapchone抗肿瘤免疫机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa9b1e6421cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734671, encodeId=37011e3467175, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Galapagos制药旗下骨关节炎药物GLPG1972 / S201086获得FDA快速通道认定, objectType=article, longId=154602, objectId=df4f15460274, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df4f15460274, replyNumber=0, likeNumber=109, createdTime=2019-04-13, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df4f15460274, moduleTitle=Galapagos制药旗下骨关节炎药物GLPG1972 / S201086获得FDA快速通道认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df4f15460274)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734673, encodeId=d2721e346734f, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Stem Cell Res Ther：研究发现骨髓间充质干细胞免疫调节对laponite成骨作用的影响, objectType=article, longId=162796, objectId=f6e6162e96a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e6162e96a6, replyNumber=0, likeNumber=83, createdTime=2019-08-26, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e6162e96a6, moduleTitle=Stem Cell Res Ther：研究发现骨髓间充质干细胞免疫调节对laponite成骨作用的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6e6162e96a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734672, encodeId=48ac1e34672bf, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Lapidus术式结合Reverdin术式治疗重度外翻1例, objectType=article, longId=158598, objectId=d47615859825, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d47615859825, replyNumber=0, likeNumber=89, createdTime=2019-06-17, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d47615859825, moduleTitle=Lapidus术式结合Reverdin术式治疗重度外翻1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d47615859825)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734668, encodeId=8b221e34668ac, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Sci Rep：在小鼠同种异体角膜移植中抗LAP单克隆抗体下调CD4+ LAP+ T细胞, objectType=article, longId=140770, objectId=d0c2140e700d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0c2140e700d, replyNumber=0, likeNumber=74, createdTime=2019-01-12, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0c2140e700d, moduleTitle=Sci Rep：在小鼠同种异体角膜移植中抗LAP单克隆抗体下调CD4+ LAP+ T细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0c2140e700d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734666, encodeId=3f031e3466683, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=J Laparoendosc Adv Surg Tech A：腹腔镜胆囊切除术后腔内使用罗哌卡因及罗哌卡因-芬太尼合剂镇痛效果的比较：随机、双盲、安慰剂对照试验, objectType=article, longId=135109, objectId=81fa135109f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81fa135109f2, replyNumber=0, likeNumber=83, createdTime=2018-10-23, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81fa135109f2, moduleTitle=J Laparoendosc Adv Surg Tech A：腹腔镜胆囊切除术后腔内使用罗哌卡因及罗哌卡因-芬太尼合剂镇痛效果的比较：随机、双盲、安慰剂对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81fa135109f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734667, encodeId=17ff1e34667d5, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Stem Cell Res Ther：骨髓间充质干细胞免疫调节对Laponite成骨作用的影响, objectType=article, longId=135371, objectId=0d6f1353e176, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d6f1353e176, replyNumber=0, likeNumber=69, createdTime=2018-06-01, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d6f1353e176, moduleTitle=Stem Cell Res Ther：骨髓间充质干细胞免疫调节对Laponite成骨作用的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d6f1353e176)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734670, encodeId=13c31e346704f, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Motif Bio的新型抗生素iclaprim获得美国优先审查, objectType=article, longId=146657, objectId=966d14665ef3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=966d14665ef3, replyNumber=0, likeNumber=88, createdTime=2018-10-29, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=966d14665ef3, moduleTitle=Motif Bio的新型抗生素iclaprim获得美国优先审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=966d14665ef3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734669, encodeId=f5dd1e346699a, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=Adv Healthc Mater：Laponite扩散凝胶可作为骨组织工程支架有效促进骨再生, objectType=article, longId=141161, objectId=0e9a14116189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e9a14116189, replyNumber=0, likeNumber=97, createdTime=2018-10-03, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e9a14116189, moduleTitle=Adv Healthc Mater：Laponite扩散凝胶可作为骨组织工程支架有效促进骨再生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e9a14116189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1734664, encodeId=d20d1e34664b9, content=<a href='/topic/show?id=2239106951c' target=_blank style='color:#2F92EE;'>#LAP#</a>, objectTitle=NEJM：BRCA生殖系突变阳性的晚期乳腺癌：奥拉帕尼（Olaparib）有力回天？, objectType=article, longId=108612, objectId=fcb31086129c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcb31086129c, replyNumber=0, likeNumber=95, createdTime=2018-07-11, rootId=0, userName=LSJ122, userId=06de33803044, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcb31086129c, moduleTitle=NEJM：BRCA生殖系突变阳性的晚期乳腺癌：奥拉帕尼（Olaparib）有力回天？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcb31086129c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

LAP

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#TGF-β# #低温电镜# #LAP#

2024-09-22发表于安徽省

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Clin Cancer Res: Olaparib(奥拉帕利)单药维持治疗亚洲人群铂敏感复发卵巢癌的疗效：III期临床研究L-MOCA

2022-12-29

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

SLAP损伤机制与分型

2023-06-11

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Eur Urol Focus：机器人辅助与腹腔镜前列腺根治术：多中心随机对照LAP-01试验的12个月结果

2022-10-05

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Br J Cancer：Olaparib奥拉帕尼联合半胸放疗提高肺癌的治疗指数

2021-10-03

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

ASCO GU 2021: ctDNA检测能有效判断Olaparib对去势抵抗性前列腺癌效果（PROfound研究）

2021-05-29

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

武田完成向Cheplapharm出售部分非核心资产

2021-03-21

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

LYNPARZA（olaparib）联合贝伐单抗一线治疗HRD阳性晚期卵巢癌：已获FDA首肯

2020-07-17

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Gastroenterology：belapectin用于治疗非酒精性脂肪性肝炎、肝硬化和门脉高压患者

2020-12-28

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Iclaprim不会在ABSSSI患者中引起高钾血症

2020-01-06

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Nat Commun丨傅阳心/黄秀梅合作破解抗癌药β-Lapchone抗肿瘤免疫机制

2020-03-30

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Galapagos制药旗下骨关节炎药物GLPG1972 / S201086获得FDA快速通道认定

2019-04-13

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Stem Cell Res Ther：研究发现骨髓间充质干细胞免疫调节对laponite成骨作用的影响

2019-08-26

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Lapidus术式结合Reverdin术式治疗重度外翻1例

2019-06-17

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Sci Rep：在小鼠同种异体角膜移植中抗LAP单克隆抗体下调CD4+ LAP+ T细胞

2019-01-12

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

J Laparoendosc Adv Surg Tech A：腹腔镜胆囊切除术后腔内使用罗哌卡因及罗哌卡因-芬太尼合剂镇痛效果的比较：随机、双盲、安慰剂对照试验

2018-10-23

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Stem Cell Res Ther：骨髓间充质干细胞免疫调节对Laponite成骨作用的影响

2018-06-01

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Motif Bio的新型抗生素iclaprim获得美国优先审查

2018-10-29

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

Adv Healthc Mater：Laponite扩散凝胶可作为骨组织工程支架有效促进骨再生

2018-10-03

LSJ122 (审核中...)

前往app查看评论内容

#LAP#

NEJM：BRCA生殖系突变阳性的晚期乳腺癌：奥拉帕尼（Olaparib）有力回天？

2018-07-11

科室
- - 订阅+
  - 更多科室
工具
服务